Neogenomics Settlement Comes in Under Accrued Reserves
Dow Jones
Jul 21
NeoGenomics finalized a civil settlement with the Department of Justice, resolving an investigation into consulting services the company provided to health care providers through its Laboratory Collaboration Initiative. The settlement of $9.8 million, plus interest at a rate of 4.25%, falls below the $11.2 million in reserves the company previously disclosed in SEC filings. NeoGenomics is set to report second-quarter results on July 28.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
(END) Dow Jones Newswires
July 20, 2026 17:46 ET (21:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.